Related Experiment Videos
Repressible antisense inhibition in B lymphocytes
1Centenary Institute of Cancer Medicine and Cell Biology, New South Wales, Australia. m.mccall@centenary.usyd.edu.au
Biochimica Et Biophysica Acta
|April 18, 1998
Summary
The tetracycline-responsive promoter (TRP) system enables repressible antisense inhibition of gene expression in B lymphocytes. This system effectively reduces IgM secretion, with levels restored upon tetracycline addition, demonstrating specific and controllable gene silencing.
Area of Science:
- Immunology
- Molecular Biology
- Gene Regulation
Background:
- Antisense technology offers potential for targeted gene silencing.
- Controlling gene expression in specific cell types like B lymphocytes is crucial for understanding immune responses and developing therapies.
- The tetracycline-responsive promoter (TRP) system provides a mechanism for inducible gene expression control.
Purpose of the Study:
- To investigate the efficacy of the TRP system for achieving repressible antisense inhibition of gene expression in a B lymphocyte model.
- To assess the impact of antisense constructs on immunoglobulin M (IgM) secretion and mRNA levels in B cells.
- To determine if antisense-mediated inhibition of IgM expression is reversible using tetracycline.
Main Methods:
- Stable transfection of the HO-2.2 B cell line with plasmid constructs containing antisense or sense DNA targeting the 3'-untranslated region of IgM.
- Utilizing the tetracycline-responsive promoter (TRP) to control the expression of antisense/sense constructs.
- Quantification of secreted IgM protein and mRNA levels via ELISA and hybridization studies.
- Assessment of membrane IgM protein levels.
- Evaluation of tetracycline's effect on IgM secretion in transfected cells.
Main Results:
- Antisense plasmids driven by the TRP significantly reduced IgM secretion (approx. 90%) in B lymphocytes.
- Tetracycline administration restored IgM secretion to control levels, confirming the repressibility of the antisense inhibition.
- No significant effect was observed on membrane IgM protein levels.
- Hybridization studies indicated that reduced protein production correlated with decreased RNA levels, suggesting post-transcriptional gene silencing.
Conclusions:
- The TRP system is effective for achieving repressible and specific antisense inhibition of gene product expression in B lymphocytes.
- This study demonstrates the potential of inducible antisense strategies for modulating gene expression in immune cells.
- The findings support the use of TRP-regulated antisense technology for research and therapeutic applications in B cell-related conditions.